Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Nextgen to launch medical tourism program

6/27/24 ABIO

Diasoft reported for 2023 by IFRS

6/27/24 DIAS

Shareholders of Mosenergo approved dividends for 2023

6/27/24 MSNG

Pyaterochka launches new franchise format

6/27/24 X5

VseInstrumenty.ru began accepting applications for participation in the IPO

6/27/24 VSEH

Bank Saint-Petersburg established a leasing company

6/26/24 BSPB

Medsi will develop the resort area

6/26/24 AFKS

Nizhny Novgorod Refinery launches AVT-6 unit

6/26/24 LKOH

VK launched a unified authorization service for businesses and developers

6/26/24 VKCO

Softline will create a platform for automation of business processes in the retail industry

6/26/24 SOFL